United States · FDA National Drug Code directory
Fosaprepitant
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0591-4385_89783971-3346-4ff8-ac47-d824a7ddf75d
- Product NDC
- 0591-4385
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- fosaprepitant
- Labeler
- Actavis Pharma, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190919
- Source listing expiry
- 20261231
Source-listed ingredients
- FOSAPREPITANT DIMEGLUMINE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (0591-4385-79) · 0591-4385-79
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →